Pharmaceutical compositions comprising tyrphostins
US6426366B1 · kind B1 · utility
10Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 1999 |
| Grant date | Jul 30, 2002 |
| Priority date | — |
| Expiry date | Apr 7, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds useful for countering undesired toxic effects to cells, tissues or organs having formula (I) wherein: Ar is a group of formulae (i) or (ii), n is 0 or, when Ar has formula (i) above, then n may also be 1, R is CN, —GC(S)NH2, —C(O)NHR3 or, when R1 is 4-NO2 add R2 is H or 3-OH, then R may also be a group of formulae (iii), (iv), (v), (vi) where R3 is H, phenyl, phenyl(lower alkyl) or pyridylmethyl; R1 and R2 are each independently H, OH, NO2 or, when R is CN, also CH3, F, or CF3, provided that both R1 and R2 are not simultaneously H.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.